These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8077931)

  • 21. Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation.
    Espigado I; de la Cruz-Vicente F; BenMarzouk-Hidalgo OJ; Gracia-Ahufinger I; Garcia-Lozano JR; Aguilar-Guisado M; Cisneros JM; Urbano-Ispizua A; Perez-Romero P
    Transpl Int; 2014 Dec; 27(12):1253-62. PubMed ID: 25070273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
    Jeitziner SM; Walton SM; Torti N; Oxenius A
    Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.
    Jonjić S; Pavić I; Polić B; Crnković I; Lucin P; Koszinowski UH
    J Exp Med; 1994 May; 179(5):1713-7. PubMed ID: 8163949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands.
    Lucin P; Pavić I; Polić B; Jonjić S; Koszinowski UH
    J Virol; 1992 Apr; 66(4):1977-84. PubMed ID: 1312614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.
    Mansfield S; Dwivedi V; Byrd S; Trgovcich J; Griessl M; Gutknecht M; Cook CH
    J Med Virol; 2016 Aug; 88(8):1408-16. PubMed ID: 26762116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
    Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
    J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis.
    Andrews DM; Andoniou CE; Granucci F; Ricciardi-Castagnoli P; Degli-Esposti MA
    Nat Immunol; 2001 Nov; 2(11):1077-84. PubMed ID: 11668340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment of cytomegalovirus-specific cellular immune response as a risk factor for cytomegalovirus disease in transplant recipients.
    Motta VN; Martins SL
    Braz J Med Biol Res; 2008 Jan; 41(1):5-11. PubMed ID: 18060322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine models of cytomegalovirus-associated pneumonitis.
    Shanley JD
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):12-6, discussion 16. PubMed ID: 1648814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenicity: animal models.
    Bruggeman CA; Li F; Stals FS
    Scand J Infect Dis Suppl; 1995; 99():43-50. PubMed ID: 8668942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection.
    Oduro JD; Redeker A; Lemmermann NAW; Ebermann L; Marandu TF; Dekhtiarenko I; Holzki JK; Busch DH; Arens R; Čičin-Šain L
    J Gen Virol; 2016 Jan; 97(1):185-195. PubMed ID: 26555192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly.
    Weinberger B; Lazuardi L; Weiskirchner I; Keller M; Neuner C; Fischer KH; Neuman B; Würzner R; Grubeck-Loebenstein B
    Hum Immunol; 2007 Feb; 68(2):86-90. PubMed ID: 17321897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus.
    Stoddart CA; Cardin RD; Boname JM; Manning WC; Abenes GB; Mocarski ES
    J Virol; 1994 Oct; 68(10):6243-53. PubMed ID: 8083964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissemination and replication of MCMV after supraciliary inoculation in immunosuppressed BALB/c mice.
    Duan Y; Ji Z; Atherton SS
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1124-31. PubMed ID: 8125723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of reactivated latent murine cytomegalovirus infection.
    Shanley JD; Jordan MC; Cook ML; Stevens JG
    Am J Pathol; 1979 Apr; 95(1):67-80. PubMed ID: 219700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced expression of gamma interferon in serum and marked lymphoid depletion induced by Porphyromonas gingivalis increase murine morbidity and mortality due to cytomegalovirus infection.
    Stern J; Shai E; Zaks B; Halabi A; Houri-Haddad Y; Shapira L; Palmon A
    Infect Immun; 2004 Oct; 72(10):5791-8. PubMed ID: 15385479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood.
    Chen SF; Tu WW; Sharp MA; Tongson EC; He XS; Greenberg HB; Holmes TH; Wang Z; Kemble G; Manganello AM; Adler SP; Dekker CL; Lewis DB; Arvin AM
    J Infect Dis; 2004 May; 189(9):1619-27. PubMed ID: 15116298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.
    Reddehase MJ; Mutter W; Münch K; Bühring HJ; Koszinowski UH
    J Virol; 1987 Oct; 61(10):3102-8. PubMed ID: 3041033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.